Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.

NCT05516537

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • University of Illinois at Chicago Chicago, Illinois, United States
View Trial Details
Completed

Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.

NCT06395662

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Texas, Southwestern Dallas, Texas, United States
  • COTE D'AZUR UNIVERSITY, URRIS-UR2CA. Hôpital Pasteur 2, 30, Voie Romaine Nice, Alpes-Maritimes, France
  • INTERNATIONAL CENTER OF RESEARCH IN INFECTIOLOGY, LYON UNIVERSITY, INSERM U1111, CNRS UMR 5308, ENS, UCBL 46 Allée d'Italie Lyon, Rhône, France
View Trial Details
Completed

Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies

NCT05566756

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Bamberg, Bavaria, Germany
  • Novartis Investigative Site Bad Homburg, Hesse, Germany
  • Novartis Investigative Site Frankfurt am Main, Hesse, Germany
View all 40 locations
View Trial Details
Completed

LEMTRADA Pregnancy Registry in Multiple Sclerosis

NCT03774914

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Site Number : 840999 New York, United States
  • Investigational Site Number : 036001 Box Hill, Victoria, Australia
  • Investigational Site Number : 040-001 Linz, Austria
  • Investigational Site Number : 56 Charleroi, Belgium
View Trial Details

Related conditions